CDK2 and cancer: Some cancer proteins such as IGF-1R kinase proteins, CDK-2, and CDK-6 bind to anthocyanidins, namely petunidin, peonidin, malvidin, pelargonidin, delphinidin, and cyanidin, thus anthocyanidins are promising metabolites for the development of cancer drugs (Sravani et al., 2021).